deltatrials
Completed PHASE2 NCT00009009

Kidney Transplant for HIV-Infected Patients in Renal Failure

Renal Allotransplantation for Treatment of End Stage Renal Disease in the Setting of Human Immunodeficiency Virus (HIV) Infection

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions Chronic Kidney Failure HIV Infection
Interventions immunosuppressive regimen designed to complement HAART
Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: Jan 31, 2001 Completion: Dec 31, 2002

This PHASE2 trial investigates Chronic Kidney Failure and HIV Infection and is currently completed. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leads this study, which shows 5 recorded versions since 2001 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jan 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bethesda, United States